The European Consortium for Continuous Pharmaceutical Manufacturing (ECCPM) was established with the aim of tackling the challenges of transferring continuous manufacturing (CM) concepts from research and development to production scale.  

The consortium serves as a pivotal platform for multinational corporations, academic institutions and industry stakeholders, facilitating the exchange of insights, best practices, and develop a collective vision on CM. Our efforts are channeled through routine pre-competitive workshops and forums, where we address the multifaceted challenges encountered in the adoption of CM processes and the development of CM-based product strategies.  

REASONS TO JOIN ECCPM

To define the contextualization of CM within the global pharmaceutical sector, we have chosen a practical “use cases” approach. These use cases focuses on the investigation, development and implementation of continuous manufacturing strategies – from API synthesis, and downstreaming to the final dosage form.  

The knowledge and insights gleaned from these use cases guide thematic focus of the annual ECCPM Forum. The Forum welcomes attendees from diverse pharmaceutical organizations worldwide and features key note lectures on relevant industrial and scientific topics shaping the future of continuous manufacturing in the pharmaceutical industry.